<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01194310</url>
  </required_header>
  <id_info>
    <org_study_id>Phako/ELT/Trabectome-12m</org_study_id>
    <nct_id>NCT01194310</nct_id>
  </id_info>
  <brief_title>Phaco vs. Phaco-ELT vs. Phaco-Trabectome 12m</brief_title>
  <official_title>Longtime Efficiency of Combined Cataract-Surgery and Excimer-Laser-Trabeculotomy or Trabectome in Glaucoma Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares efficacy (i.e. IOP and hypotensive medications) of phaco alone vs.
      combined phaco plus excimer laser trabeculotomy vs. combined phaco plus trabectome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Glaucoma is one of the most common reasons for blindness. Usually an elevated drain
      resistance is the reason, while aqueous humor production is normal. Medical reduction of
      intraocular pressure (IOP) is first line therapy in most cases. The gold standard of surgical
      treatment still is trabeculectomy (TE) but TE has a lot of drawbacks. In particular when
      glaucoma and cataract coexists, the investigators therefore prefer the combined procedure
      cataract extraction plus excimer laser trabeculotomy (ELT) or plus Trabectome. Indication is
      cataract and a moderate elevated IOP without medical therapy or a moderate cataract and
      elevated IOP with medical therapy.

      The ELT is performed by an AIDA XeCl-Excimer Laser System (TUI-Laser AG, Germering, 1,2 mJ
      per burst, burst duration 16 ns, wave length 308 nm, spot diameter 200 Âµm). 10 foramina were
      made over 90 degrees of the anterior chamber angle. Trabectome procedure is performed with
      the Trabectome unit from Neomedix.

        -  Trial with medical device

        -  Trial with surgical intervention
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2009</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">245</enrollment>
  <condition>Glaucoma</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>phaco alone</arm_group_label>
    <description>patients w/ diagnosis of open angle glaucoma underwent phaco alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>phaco-ELT</arm_group_label>
    <description>patients w/ diagnosis of open angle glaucoma underwent combined phaco plus ELT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>phaco-Trabectome</arm_group_label>
    <description>patients w/ diagnosis of open angle glaucoma underwent combined phaco plus Trabectome</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phaco</intervention_name>
    <description>Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) alone</description>
    <arm_group_label>phaco alone</arm_group_label>
    <arm_group_label>phaco-ELT</arm_group_label>
    <arm_group_label>phaco-Trabectome</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phaco-ELT</intervention_name>
    <description>Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) plus excimer laser trabeculotomy (ELT)</description>
    <arm_group_label>phaco-ELT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phaco-Trabectome</intervention_name>
    <description>Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) plus Trabectome</description>
    <arm_group_label>phaco-Trabectome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  All patients, which had Phaco, Phako/ELT, or Phaco-Trabectome from 01/2008 until
             12/2011, where screened 12 month after surgery

        Exclusion criteria:

          -  IOP &gt;35 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2010</study_first_submitted>
  <study_first_submitted_qc>September 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2010</study_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <keyword>cataract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

